Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Healthcare Services (HCSG) over the last 17 years, with Q3 2025 value amounting to $124.4 million.

  • Healthcare Services' Cash & Equivalents rose 35975.97% to $124.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.4 million, marking a year-over-year increase of 35975.97%. This contributed to the annual value of $56.8 million for FY2024, which is 450.21% up from last year.
  • Latest data reveals that Healthcare Services reported Cash & Equivalents of $124.4 million as of Q3 2025, which was up 35975.97% from $82.8 million recorded in Q2 2025.
  • Healthcare Services' 5-year Cash & Equivalents high stood at $124.6 million for Q2 2021, and its period low was $16.2 million during Q1 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $32.9 million (2022), whereas its average is $55.3 million.
  • As far as peak fluctuations go, Healthcare Services' Cash & Equivalents plummeted by 7532.98% in 2022, and later soared by 35975.97% in 2025.
  • Healthcare Services' Cash & Equivalents (Quarter) stood at $70.8 million in 2021, then tumbled by 62.88% to $26.3 million in 2022, then skyrocketed by 106.74% to $54.3 million in 2023, then grew by 4.5% to $56.8 million in 2024, then skyrocketed by 119.09% to $124.4 million in 2025.
  • Its Cash & Equivalents was $124.4 million in Q3 2025, compared to $82.8 million in Q2 2025 and $64.3 million in Q1 2025.